Advertisement
Screener

ZS Pharma, Inc. Share-based Payment Arrangement, Expense

ZS Pharma, Inc. Share-based Payment Arrangement, Expense

ZS Pharma, Inc. reported Share-based Payment Arrangement, Expense of $6.40 million for the 3-month period ending 2015-06-30, per its 10-Q filed 2015-08-06.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2015-08-06

  • ZS Pharma, Inc. share-based payment arrangement, expense for the quarter ending 2015-06-30 was $6.40M.
  • ZS Pharma, Inc. share-based payment arrangement, expense for fiscal 2013 was $1.90M.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 12 month
2015-06-30$6.40M
10-Q · filed 2015-08-06
2013-12-31$1.90M
10-K · filed 2015-03-13